Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2010
12/30/2010US20100330039 Schizochytrium Fatty Acid Synthase (FAS) and Products and Methods Related Thereto
12/30/2010US20100330038 Methods for expressing proteins in axons
12/30/2010US20100330037 Adenoviral systems and the uses thereof
12/30/2010US20100330036 Markers of matrix gene expression and cellular differentiation in chondrocytes
12/30/2010US20100330035 Pharmaceutical Compositions for Treatment of HCV Patients that are Poor-Responders to Interferon
12/30/2010US20100330034 Use of bispecific antibodies to regulate immune responses
12/30/2010US20100330032 Heterocyclic antiviral compounds
12/30/2010US20100330001 Antibacterial compositions
12/30/2010US20100329995 Compositions containing lactoferrin, and methods of using same to promote growth of skin cells
12/30/2010US20100329990 Luminescent markers
12/30/2010US20100329987 Uses of Sperm Membrane Protein OBF
12/30/2010US20100329986 Adult Hepatic Progenitor Cells and Methods of Use Thereof
12/30/2010US20100329983 Compounds and methods for the detection of trpv-6 cancers and drug delivery
12/30/2010US20100329980 Humanized anti-alpha 9 integrin antibodies and the uses thereof
12/29/2010WO2010151782A1 Differentiated pluripotent stem cell progeny depleted of extraneous phenotypes
12/29/2010WO2010151733A1 Dental stem cell reprogramming
12/29/2010WO2010151517A2 Antigen-specific long-term memory t-cells
12/29/2010WO2010150862A1 Fluorescent temperature probe and temperature measuring device using same
12/29/2010WO2010150773A1 Personal box for collection preparation, collection preparation system, and collection preparation method
12/29/2010WO2010150708A1 Protein-modifying agent
12/29/2010WO2010150650A1 Novel method for maintaining stem cells in an undifferentiated state
12/29/2010WO2010150525A1 Urate transporter, as well as method and kit for evaluating urate transport-related disease factor and inflammation-related disease factor, and test sample and drug
12/29/2010WO2010150521A1 Culture substrate, culture sheet, and cell culture method
12/29/2010WO2010150094A1 Mesenchymal stem cells grown under hypoxic conditions: compositions, methods and uses therefor
12/29/2010WO2010149809A1 Device and method for the three-dimensional culture of adherent cells
12/29/2010WO2010149597A2 3D CULTURING SYSTEMS FOR GROWTH AND DIFFERENTIATION OF HUMAN PLURIPOTENT STEM (hPS) CELLS
12/29/2010WO2010128024A3 Reversibly immortalized cells as well as methods relating hereto
12/29/2010WO2010091052A3 Methods for enhancing hematopoietic stem/progenitor cell engraftment
12/29/2010WO2010068278A3 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
12/29/2010EP2267452A1 A soluble complex comprising a retroviral surface glycoprotein
12/29/2010EP2267431A2 Gas sensor
12/29/2010EP2267140A1 Improved genetic elements providing high levels of expression
12/29/2010EP2267139A2 Methods and means for obtaining modified phenotypes
12/29/2010EP2267138A2 Methods and means for obtaining modified phenotypes
12/29/2010EP2267135A2 Protein glycosylation modification in pichia pastoris
12/29/2010EP2267131A1 Genetic inhibition by double-stranded RNA
12/29/2010EP2267123A2 Compositions and methods for modulating lignin of a plant
12/29/2010EP2267118A1 Method for production of transfected cell
12/29/2010EP2267117A2 Differentiation modulating agents and uses therefor
12/29/2010EP2267116A1 Growth medium for primate embryonic stem cells
12/29/2010EP2267115A1 Anterior ocular segment related cell sheets, three-dimensional structures, and processes for producing the same
12/29/2010EP2267114A2 Tissue engineering using pure populations of isolated non-embryoblastic fetal cells
12/29/2010EP2267026A1 Albumin fusion proteins
12/29/2010EP2267023A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267022A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267021A2 KDR peptides and vaccines comprising the same
12/29/2010EP2267013A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267012A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267011A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2267007A1 New gene products of bacillus licheniformis forming or decomposing polyamino acids and associated improved biotechnological production method
12/29/2010EP2266627A1 Single-stranded oligodeoxynucleotide mutational vectors
12/29/2010EP2266621A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics
12/29/2010EP2266620A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics
12/29/2010EP2266616A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266615A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266613A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266612A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy
12/29/2010EP2266543A2 Non-polymeric hematopoietic cell clots for delivery of active agents
12/29/2010EP2266500A2 Three-dimensional tissue structure
12/29/2010EP2266499A2 Three-dimensional tissue structure
12/29/2010EP2266396A2 Modulation of stem cells using zinc finger proteins
12/29/2010EP2265712A1 Cell line from rousettus as host cell for pathogen amplification
12/29/2010EP2265711A1 Membrane
12/29/2010EP2265710A1 Human adipose derived insulin making mesenchymal stem cells for treating diabetes mellitus
12/29/2010EP2265708A2 Methods for stem cell production and therapy
12/29/2010EP1692275B1 Method and system for preparing stem cells from fat tissue
12/29/2010EP1685405B1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
12/29/2010EP1670935B1 Neural colony forming assay
12/29/2010EP1539228B1 Novel composition and methods for the treatment of immune related diseases
12/29/2010EP1497415B1 Methods for detection or modulation of the interaction of a cytokine receptor with its ligand
12/29/2010EP1496122B1 Novel meloidogyne-resistance gene and utilization thereof
12/29/2010EP1404849B1 Modification of plant genomes by inducible site-specific recombination of transgenes
12/29/2010EP1256625B1 Immortalized vascular adventitial cell line
12/29/2010EP1127069B1 Method of making a monomeric beta-form of a prion protein
12/29/2010CN1948342B HLA-A2 restriction epi polypeptide originated from post selection cancer gene hRabj and its application
12/29/2010CN1901802B Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
12/29/2010CN101932708A Improved gene silencing methods
12/29/2010CN101932704A Polypeptides having xylanase activity and polynucleotides encoding same
12/29/2010CN101932608A Antigen-binding constructs
12/29/2010CN101928728A Method for preparing enterovirus virus-like particle and application thereof
12/29/2010CN101928717A Salvia miltrorrhiza squalene synthase (SmSQS) gene and encoding protein and application thereof
12/29/2010CN101928716A SmFPS (Salviamiltiorrhizabge Farnesyl Pyrophosphate Synthase) gene as well as coded protein and application thereof
12/29/2010CN101928715A Salviamiltiorrhizabge-cytochrome P450 (SmP450) gene as well as coded protein and application thereof
12/29/2010CN101928712A Plants having modified growth characteristics and a method for making the same
12/29/2010CN101928700A Protein kinase PFTK1 monoclonal antibody and preparation method thereof
12/29/2010CN101928693A Method for culturing primary cells
12/29/2010CN101928692A Differentiated cells suitable for human therapy
12/29/2010CN101928458A Preparation method of multifunctional nanometer composite particle constructed by modified polymine
12/29/2010CN101928347A Anti-carcinoembryonic-antigen (CEA) antibody and application thereof
12/29/2010CN101928345A Human source antibody and humanization remolding method thereof
12/29/2010CN101928344A Human monoclonal antibodies against cd20
12/29/2010CN101928339A Bambusa affinis 'viridiflavus' aging associated transcription factor, coding gene thereof and use thereof
12/29/2010CN101928338A Cotton GbVe gene, protein coded thereby and use thereof in vegetable verticillium wilt resistance
12/29/2010CN101928337A Chrysanthemum drought-tolerant gene and application thereof
12/29/2010CN101928336A Phosphorus deficiency response regulatory protein and coding gene and application thereof
12/29/2010CN101928308A Method for preparing salidroside by using RsTyrDC
12/29/2010CN101926824A Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
12/29/2010CN101926284A Monkshood-tuber tissue culture and rapid propagation method
12/29/2010CN101385440B Quick propagation method of Tectona grandis
12/29/2010CN101336613B Black bamboo tissue culture medium and tissue culture and rapid propagation method
1 ... 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 ... 1827